@article{3165062,
    title = "Investigating the economic burden of ALS in Greece: A cost-of-illness
approach",
    author = "Athanasakis, Kostas and Kyriopoulos, Ilias-Ioannis and Sideris, Manthos and and Rentzos, Michael and Evdokimidis, John and Kyriopoulos, John",
    journal = "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration",
    year = "2015",
    volume = "16",
    number = "1-2",
    pages = "63-64",
    publisher = "TAYLOR & FRANCIS LTD LONDON",
    issn = "2167-8421, 2167-9223",
    doi = "10.3109/21678421.2014.932384",
    keywords = "Cost-of-illness; amyotrophic lateral sclerosis; health economics",
    abstract = "The present study aims to investigate the economic burden of ALS per
patient in Greece. A sample of 33 patients who were monitored in
Aeginition University Hospital in Athens, a reference centre for ALS in
Greece, was used for the calculations. According to the findings of this
study the total annual cost per ALS patient in Greece was (sic) 7450.
The direct cost was estimated at (sic) 4305 (or 57.8% of the total
cost), while the indirect cost was (sic) 3145 (or 42.2% of the total
cost). Medications, professional home help and cost due to work
absenteeism were the leading components of total cost. In general, the
aforementioned amount is considered substantial, albeit lower than the
corresponding amount of other countries."
}